Skip to Content
Merck

Key Documents

View All Documentation

H6377

1-Hydroxypyridine-2-thione zinc salt

≥95%

Synonym(s):

Mercaptopyridine N-oxide zinc salt, Pyrithione

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C10H8N2O2S2Zn
CAS Number:
13463-41-7
Molecular Weight:
317.70
NACRES:
NA.22
PubChem Substance ID:
57654263
UNSPSC Code:
12352100
EC Number:
236-671-3
MDL number:
MFCD00067336
Assay:
≥95%
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

100

assay

≥95%

SMILES string

O1N2C=CC=CC2=[S][Zn]13ON4C=CC=CC4=[S]3

InChI

1S/2C5H5NOS.Zn/c2*7-6-4-2-1-3-5(6)8;/h2*1-4,8H;/q;;+2/p-2

InChI key

OTPSWLRZXRHDNX-UHFFFAOYSA-L

Application


  • Antimicrobial nanocoatings: The compound 1-Hydroxypyridine-2-thione zinc salt was evaluated for its efficacy in antimicrobial nanocoatings, showcasing its role in enhancing the performance of such coatings used in healthcare and industrial environments to prevent microbial contamination (Molling et al., 2014).

signalword

Danger

Hazard Classifications

Acute Tox. 2 Inhalation - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1 - Repr. 1B - STOT RE 1

Storage Class

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk

WGK 3

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

13463-41-7

CAS No.

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCX4225
MKCW9769
MKCT8891
MKCQ6554
MKCL4181

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

J R Schwartz et al.
The British journal of dermatology, 165 Suppl 2, 18-23 (2011-09-23)
Pathogenesis of dandruff/seborrhoeic dermatitis (D/SD) involves Malassezia yeasts, leading to the most widely accepted treatment strategy of topical application of antifungal agents, usually from rinse-off shampoos. The scalp spatial distribution of Malassezia must be mirrored by the distribution of the
K J Mills et al.
The British journal of dermatology, 166 Suppl 2, 33-40 (2012-06-15)
Dandruff/seborrhoeic dermatitis is a common scalp condition that is characterized by flakes, pruritus and sometimes mild erythema. These symptoms reflect tissue level events that are poorly understood at the molecular level. The purpose of this work was: (i) to compare
M Tailler et al.
Oncogene, 31(30), 3536-3546 (2011-11-23)
Despite recent progress in the treatment of acute myeloid leukemia (AML), the prognosis of this rather heterogeneous disease remains poor and novel chemotherapeutics that specifically target leukemic cells must be developed. To address this need at the preclinical level, we
View All Related Papers